BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 37923243)

  • 1. Wild-type cardiac amyloidosis with a negative bone scintigraphy: A case report.
    Lima MR; Rocha BM; Marques A; Aguiar CMT
    Rev Port Cardiol; 2024 Mar; 43(3):163-165. PubMed ID: 37923243
    [No Abstract]   [Full Text] [Related]  

  • 2. Negative bone scintigraphy in wild-type transthyretin cardiac amyloidosis.
    Martini N; Rizzo S; Sarais C; Cipriani A
    BMC Cardiovasc Disord; 2020 Oct; 20(1):466. PubMed ID: 33121442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randall-Type Monoclonal Immunoglobulin Deposition Disease in Bone Scintigraphy.
    Jacquet-Francillon N; Dijoud F; Karlin L; Dietz M; Flaus A; Tordo J
    Clin Nucl Med; 2023 Dec; 48(12):e611-e613. PubMed ID: 37883135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of cardiac amyloidosis incidentally detected by bone scintigraphy.
    Tanaka H; Hosono M; Kanagaki M; Shimizu M; Matsubara N; Kawabata K; Miyamoto T; Itoi K
    Asia Ocean J Nucl Med Biol; 2021; 9(1):71-75. PubMed ID: 33392354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta 2-microglobulin: case report of a rare cause of cardiac amyloidosis.
    Haslett JJ; Patel JK; Kittleson MM
    Eur Heart J Case Rep; 2023 May; 7(5):ytad239. PubMed ID: 37223323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Awareness of Nuclear Medicine Physicians in Romania Regarding the Diagnostic of Cardiac Amyloidosis-A Survey-Based Study.
    Stan C; Mititelu R; Adam RD; Jurcuţ R
    Diagnostics (Basel); 2022 Feb; 12(2):. PubMed ID: 35204645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case report of an uncommon presentation of
    Ochi Y; Kubo T; Nakashima Y; Takahashi A; Baba Y; Hirota T; Yamasaki N; Kitaoka H
    J Cardiol Cases; 2020 Feb; 21(2):50-53. PubMed ID: 32042354
    [No Abstract]   [Full Text] [Related]  

  • 8. Non-invasive detection and differentiation of cardiac amyloidosis using
    Takasone K; Katoh N; Takahashi Y; Abe R; Ezawa N; Yoshinaga T; Yanagisawa S; Yazaki M; Oguchi K; Koyama J; Sekijima Y
    Amyloid; 2020 Dec; 27(4):266-274. PubMed ID: 32722948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A challenging road to diagnosing transthyretin cardiac amyloidosis and using technetium-99m pyrophosphate bone scintigraphy in nuclear cardiology - A case report.
    Kavita A; Abdul Onny MA; Suppiah S; Abdul Aziz AF; Hashim H; Raja Shariff RE; Ng CS
    Med J Malaysia; 2021 Sep; 76(5):762-767. PubMed ID: 34508392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone scintigraphy with (99m)technetium-hydroxymethylene diphosphonate allows early diagnosis of cardiac involvement in patients with transthyretin-derived systemic amyloidosis.
    Glaudemans AW; van Rheenen RW; van den Berg MP; Noordzij W; Koole M; Blokzijl H; Dierckx RA; Slart RH; Hazenberg BP
    Amyloid; 2014 Mar; 21(1):35-44. PubMed ID: 24455993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Case Report and Literature Review of Cardiac Amyloidosis: A Not-So-Rare Cause of Heart Failure.
    Baptista P; Moura de Azevedo S; Alexandre A; Dias-Frias A
    Cureus; 2023 Jan; 15(1):e33364. PubMed ID: 36751253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of echocardiography and 99mTc-HDP scintigraphy in non-invasive diagnosis of cardiac amyloidosis: A case series and literature review.
    Costache II; Buburuz AM; Crisu D; Statescu AM; Ungureanu C; Aursulesei V
    Medicine (Baltimore); 2019 Sep; 98(38):e17256. PubMed ID: 31567998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility and limitations of 3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in systemic amyloidosis.
    Hutt DF; Quigley AM; Page J; Hall ML; Burniston M; Gopaul D; Lane T; Whelan CJ; Lachmann HJ; Gillmore JD; Hawkins PN; Wechalekar AD
    Eur Heart J Cardiovasc Imaging; 2014 Nov; 15(11):1289-98. PubMed ID: 24939945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic accuracy of bone scintigraphy in the assessment of cardiac transthyretin-related amyloidosis: a bivariate meta-analysis.
    Treglia G; Glaudemans AWJM; Bertagna F; Hazenberg BPC; Erba PA; Giubbini R; Ceriani L; Prior JO; Giovanella L; Slart RHJA
    Eur J Nucl Med Mol Imaging; 2018 Oct; 45(11):1945-1955. PubMed ID: 29687207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal Trends of Wild-Type Transthyretin Amyloid Cardiomyopathy in the Transthyretin Amyloidosis Outcomes Survey.
    Nativi-Nicolau J; Siu A; Dispenzieri A; Maurer MS; Rapezzi C; Kristen AV; Garcia-Pavia P; LoRusso S; Waddington-Cruz M; Lairez O; Witteles R; Chapman D; Amass L; Grogan M;
    JACC CardioOncol; 2021 Oct; 3(4):537-546. PubMed ID: 34729526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac Scintigraphy With Technetium-99m-Labeled Bone-Seeking Tracers for Suspected Amyloidosis: JACC Review Topic of the Week.
    Hanna M; Ruberg FL; Maurer MS; Dispenzieri A; Dorbala S; Falk RH; Hoffman J; Jaber W; Soman P; Witteles RM; Grogan M
    J Am Coll Cardiol; 2020 Jun; 75(22):2851-2862. PubMed ID: 32498813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis.
    Gillmore JD; Maurer MS; Falk RH; Merlini G; Damy T; Dispenzieri A; Wechalekar AD; Berk JL; Quarta CC; Grogan M; Lachmann HJ; Bokhari S; Castano A; Dorbala S; Johnson GB; Glaudemans AW; Rezk T; Fontana M; Palladini G; Milani P; Guidalotti PL; Flatman K; Lane T; Vonberg FW; Whelan CJ; Moon JC; Ruberg FL; Miller EJ; Hutt DF; Hazenberg BP; Rapezzi C; Hawkins PN
    Circulation; 2016 Jun; 133(24):2404-12. PubMed ID: 27143678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone scintigraphy imaging of cardiac amyloidosis.
    Kuria IM; Gitau SN; Makhdomi KB
    World J Nucl Med; 2019; 18(3):314-316. PubMed ID: 31516380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic utility of the Perugini grading of 99mTc-DPD scintigraphy in transthyretin (ATTR) amyloidosis and its relationship with skeletal muscle and soft tissue amyloid.
    Hutt DF; Fontana M; Burniston M; Quigley AM; Petrie A; Ross JC; Page J; Martinez-Naharro A; Wechalekar AD; Lachmann HJ; Quarta CC; Rezk T; Mahmood S; Sachchithanantham S; Youngstein T; Whelan CJ; Lane T; Gilbertson JA; Rowczenio D; Hawkins PN; Gillmore JD
    Eur Heart J Cardiovasc Imaging; 2017 Dec; 18(12):1344-1350. PubMed ID: 28159995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multimodality assessments of wild-type transthyretin cardiac amyloidosis with no ventricular hypertrophy.
    Iwaya T; Okada A; Tateishi E; Ohta Y; Morita Y; Ohta-Ogo K; Izumi C
    ESC Heart Fail; 2023 Apr; 10(2):1412-1417. PubMed ID: 36335980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.